Recent Advances in the Effects of Mesenchymal Stem Cells on Osteoclastogenesis

doi:10.3969/j.issn.1005-4979.2016.06.014

Abstract

Abstract: The effect of mesenchymal stem cells (MSCs) on bone formation is complex and various. The effect of MSCs on osteoclastogenesis and bone resorption is a main aspect. Bone resorption is tightly and dynamically regulated by multiple mediators, including cytokines that act directly on osteoclasts and their precursors, or indirectly by modulating osteoblast lineage cells that in turn regulate osteoclast differentiation. Under some physiological conditions, the cytokines produced by MSCs have important roles in a diverse range of osteoclastogenesis processes. However, during inflammation, MSCs suppress osteoclast formation and activity, partly via paracrine effects. MSCs thus seem to have a dual effect, by stimulating or inhibiting osteoclastogenesis, depending on the inflammatory level. This effect of MSCs on osteoclast formation may be exploited for the therapeutic potential of MSCs in bone loss associated with inflammatory diseases.

Key words: mesenchymal stem cells, osteoclastogenic, paracrine

摘要： 间充质干细胞（MSCs）对骨代谢的作用是多方面的。MSCs对破骨细胞和骨吸收的调控是其中一个很重要的方面。MSCs对破骨有双面的调节作用，可能促进或者抑制，取决于炎症环境的情况。在一些生理、病理环境下，MSCs通过分泌相关细胞因子对破骨细胞的形成及功能起正向调控作用。但在某些炎症状态下，MSCs可能也通过旁分泌作用实现对破骨细胞形成和分化的抑制作用，尤其是在体外共培养破骨细胞与MSCs，MSCs对破骨细胞的形成表现出抑制作用。了解MSCs对破骨细胞的调控作用，有助于了解炎症微环境下MSCs对骨丢失的治疗潜能。

关键词: 间充质干细胞, 破骨, 旁分泌

CLC Number:

R782

XU Shu-yu, WANG Zuo-lin. Recent Advances in the Effects of Mesenchymal Stem Cells on Osteoclastogenesis[J]. 《Journal of Oral and Maxillofacial Surgery》, 2016, 26(6): 441-.

许舒宇（综述）,王佐林（审校）. 间充质干细胞调控破骨细胞分化及功能的研究进展[J]. 《口腔颌面外科杂志》, 2016, 26(6): 441-.

/ / Recommend / Download Citations

URL: https://journal06.magtech.org.cn/Jweb_joms/EN/10.3969/j.issn.1005-4979.2016.06.014

https://journal06.magtech.org.cn/Jweb_joms/EN/Y2016/V26/I6/441

References

[1]Crockett JC, Rogers MJ, Coxon FP, et al. Bone remodelling at a glance[J]. J Cell Sci, 2011, 124(Pt 7):--1---8.
[2]Hartmann ES, Kohler MI, Huber F, et al. Factors regulating bone remodelling processes in aseptic implant loosening[J]. J Orthop Res, 2016, [Epub ahead of print].
[3]Walsh MC, Choi Y. Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond[J]. Front Immunol, 2014, 5:511.
[4]Al-Nbaheen M, Vishnubalaji R, Ali D, et al. Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential[J]. Stem Cell Rev, Feb 2013, -(1):32-43.
[5]Bianco P, Robey PG. Skeletal stem cells[J]. Development, 2015, 142(6):1023-1027.
[6]Wang L, Wang L, Cong X, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy[J]. Stem Cells Dev, 2013, 22(24):31-2-3202.
[7]Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement[J]. Cytotherapy, 2006, 8(4):315-317.
[8]Meirelles Lda S, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells[J]. Cytokine Growth Factor Rev, 200-, 20(5-6):41--427.
[-]Vaananen HK, Zhao H, Mulari M, Halleen JM. The cell biology of osteoclast function[J]. J Cell Sci, 2000, 113(Pt 3):377-381.
[10]Endo-Munoz L, Evdokiou A, Saunders NA. The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis[J]. Biochim Biophys Acta, 2012, 1826(2):434-442.
[11]Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling[J]. Cytokine Growth Factor Rev, 2004, 15(6):457-475.
[12]Tanaka S, Miyazaki T, Fukuda A, et al. Molecular mechanism of the life and death of the osteoclast[J]. Ann N Y Acad Sci, 2006, 1068:180-186.
[13]Kim HJ, Yoon HJ, Kim SY, Yoon YR. A medium-chain fatty acid, capric acid, inhibits RANKL-induced osteoclast differentiation via the suppression of NF-kappaB signaling and blocks cytoskeletal organization and survival in mature osteoclasts[J]. Mol Cells, 2014, 37(8):5-8-604.
[14]Struewer J, Roessler PP, Schuettler KF, et al. Influence of cyclical mechanical loading on osteogenic markers in an osteoblast-fibroblast co-culture in vitro: tendon-to-bone interface in anterior cruciate ligament reconstruction[J]. Int Orthop, 2014, 38(5):1083-108-.
[15]Galli C, Fu Q, Wang W, et al. Commitment to the osteoblast lineage is not required for RANKL gene expression[J]. J Biol Chem, 200-, 284(1-):12654-12662.
[16]Zhu H, Jiang XX, Guo ZK, et al. Tumor necrosis factor-alpha alters the modulatory effects of mesenchymal stem cells on osteoclast formation and function[J]. Stem Cells Dev, 200-, 18(10):1473-1484.
[17]Oshita K, Yamaoka K, Udagawa N, et al. Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production[J]. Arthritis Rheum, 2011, 63(6):1658-1667.
[18] Holt V, Caplan AI, Haynesworth SE. Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules:marrow adipocytes express osteoclast mediators[J]. PLoS One, 2014, -(10):e108-20.
[1-]Takano T, Li YJ, Kukita A, et al. Mesenchymal stem cells markedly suppress inflammatory bone destruction in rats with adjuvant-induced arthritis[J]. Lab Invest. Mar, 2014, -4(3):286-2-6.
[20]Varin A, Pontikoglou C, Labat E, Deschaseaux F, Sensebe L. CD200R/CD200 inhibits osteoclastogenesis: new mechanism of osteoclast control by mesenchymal stem cells in human[J]. PLoS One, 2013, 8(8):e72831.
[21]Delorme B, Ringe J, Gallay N, et al. Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells[J]. Blood, 2008, 111(5):2631-2635.
[22]Pietila M, Lehtonen S, Tuovinen E, et al. CD200 positive human mesenchymal stem cells suppress TNF-alpha secretion from CD200 receptor positive macrophage-like cells[J]. PLoS One, 2012, 7(2):e31671.
[23]Ma L, Aijima R, Hoshino Y, et al. Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice[J]. Stem Cell Res Ther, 2015, 6:104.
[24]Siemieniuch MJ, Szostek AZ, Gajos K, Kozdrowski R, Nowak M, Okuda K. Type of Inflammation Differentially Affects Expression of Interleukin 1beta and 6, Tumor Necrosis Factor-alpha and Toll-Like Receptors in Subclinical Endometritis in Mares[J]. PLoS One, 2016, 11(5):e0154-34.
[25]Friday SC, Fox DA. Phospholipase D enzymes facilitate IL-17- and TNFalpha-induced expression of proinflammatory genes in rheumatoid arthritis synovial fibroblasts (RASF) [J]. Immunol Lett, 2016, 174:--18.
[26]Ganesan R, Doss HM, Rasool M. Majoon ushba, a polyherbal compound, suppresses pro-inflammatory mediators and RANKL expression via modulating NFκB and MAPKs signaling pathways in fibroblast-like synoviocytes from adjuvant-induced arthritic rats[J]. Immunol Res, 2016, 64(4):1071-1086.
[27]Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications[J]. Nat Immunol, 2014, 15(11):100--1016.
[28]Shi Y, Hu G, Su J, et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair[J]. Cell Res, 2010, 20(5):510-518.
[2-]Evans KE, Fox SW. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus[J]. BMC Cell Biol, 2007, 8:4.
[30]Park-Min KH, Ji JD, Antoniv T, et al. IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression[J]. J Immunol, 200-, 183(4):2444-2455.
[31]Kasagi S, Chen W. TGF-beta1 on osteoimmunology and the bone component cells[J]. Cell Biosci, 2013, 3(1):4.
[32]Zupan J, Jeras M, Marc J. Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts[J]. Biochem Med (Zagreb), 2013, 23(1):43-63.

[1]	MING Hua-Wei, HE Yun, XIA De-Lin, FU Guang-Xin, LI Biao, GAN Sheng-Yuan. VEGF 165 Gene Transfected HUVEC Promotes Angiogenesis: an in vivo Study in Rats [J]. 《Journal of Oral and Maxillofacial Surgery》, 2017, 27(3): 161-165.
[2]	CHEN Hu-Jie, DAI De-Hua, DAI Jing, WEI Wei, XIN Hai-Tao. Correlation Analysis of Toll-like receptor-4 and LPS-induced Secretion of Tumor Necrosis Factor-α from Rat Oral Mucosal Eepithelial Cells and the Underlying Mechanisms [J]. 《Journal of Oral and Maxillofacial Surgery》, 2017, 27(3): 166-171.
[3]	WANG Xiao-hu, WANG Zuo-lin. Expression of M-CSF, OPG and RANKL in Maxillary Bone-derived Mesenchymal Stem Cells in Periodontitis Model of Rat [J]. 《Journal of Oral and Maxillofacial Surgery》, 2017, 27(2): 83-88.
[4]	. Oral Myiasis: Case Report and Review of Literature [J]. 《Journal of Oral and Maxillofacial Surgery》, 2017, 27(2): 150-152.
[5]	DU Hai-ming, ZHANG Qi. Age-related Changes of Mouse Mandible after OPG Deficiency: an in vivo Micro-CT Analysis [J]. 《Journal of Oral and Maxillofacial Surgery》, 2017, 27(1): 13-.
[6]	CAI Ming-xiang, SUN Yao. Recent Advance on Bone Targeting Drug Delivery System [J]. 《Journal of Oral and Maxillofacial Surgery》, 2017, 27(1): 56-.
[7]	QI Ying, ZHAO Yu-mei. Recent Advances of Dental Pulp Stem Cells in Maxillofacial Region Tissue Engineering [J]. 《Journal of Oral and Maxillofacial Surgery》, 2016, 26(6): 446-.
[8]	WANG Shan-shan, CHENG Ji-guang, XU Wen-hua, CHEN Xin, ZHOU Jian. Comparison of Medical Calcium, β-tricalcium Phosphate, and Perioglas in the treatment of Odontogenic Cystic Cavities [J]. 《Journal of Oral and Maxillofacial Surgery》, 2016, 26(6): 431-.
[9]	ZHAO Chen-guang, WANG Jin-hui, LI Xin, ZHOU Ying-rui. Infections of Embedded Wisdom Teeth in Complete Denture Patients: a Report of 68 Cases [J]. 《Journal of Oral and Maxillofacial Surgery》, 2016, 26(6): 420-.
[10]	LI Cai, CHEN Feng-shan. Targeted Sequencing in Genes of BMP-smad Signaling Pathway for Mandibular Prognathism [J]. 《Journal of Oral and Maxillofacial Surgery》, 2016, 26(6): 399-.
[11]	YANG Shi-mao, GUO Yan-wei, LI Da-lu, WANG Ming-guo. PRF Promotes Osteogenic Differentiation of BMSCs through Activating Canonical Wnt/β-catenin Signaling Pathway [J]. 《Journal of Oral and Maxillofacial Surgery》, 2016, 26(6): 393-.
[12]	PAN Min, SUN Yao. Recent Advances of Nervous System on Bone Remodeling [J]. 《Journal of Oral and Maxillofacial Surgery》, 2016, 26(5): 368-.
[13]	TANG Yan-chi, LIANG Yi, WANG Chen-xing, DU Yi-fei, YUAN Hua, WAN Lin-zhong. Sleep Apnea due to Eosinophilic Lymphogranuloma of the Soft Palate: a Case Report [J]. 《Journal of Oral and Maxillofacial Surgery》, 2016, 26(5): 378-.
[14]	LIU Zhuo-jue, XIONG Xue-peng, ZHAO Yi-fang. Osteoradionecrosis of the Zygoma: Case Report [J]. 《Journal of Oral and Maxillofacial Surgery》, 2016, 26(4): 302-304.
[15]	LIN Jing, LI Jing-xu, ZHANG Xiang-zi, CUI Yin-feng, XUAN Yun-ze. Analysis of Effects of Combined PBL and CBL in Oral and Maxillofacial Surgery Teaching [J]. 《Journal of Oral and Maxillofacial Surgery》, 2016, 26(4): 299-301.

Please choose a citation manager

Content to export